The official CDC page on research pertaining to polysubstance use during pregnancy, suggesting ways to help reduce substance exposure during pregnancy and improve the health of women and their children.
A summary of a workshop from the National Institutes of Health (NIH) HEAL (Helping to End Addiction Long-Term) Initiative, discussing opioid use in the context of polysubstance use.
This brief examines the prevalence of diagnoses of polysubstance use disorders, describes the characteristics of Medicaid enrollees with polysubstance use disorders, and compares the mental health and medical comorbidities based on the number of unique substance use disorders.
This research report provides information on the state of the science in the comorbidity of substance use disorders with mental illness and physical health conditions.
This is an FDA warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth. Despite these risks, buprenorphine is an important treatment option for opioid use disorder (OUD) and pain, and the benefits of these medicines clearly outweigh the risks.
A Practice Guideline which includes treatment recommendations for patients with substance use disorders, as well as background information and a review of available evidence.
Describes three promising behavioral health models to improve care and access for mental health and substance use disorders, including psychiatric mental health nurses, mobile technology, and using crisis services
Reviews 28 studies about alcohol treatments delivered in primary care settings, finding that trials of naltrexone and disulfiram had positive results, but that more studies are needed to assess the effectiveness of the full scope of alcohol treatment